Centrus Energy (LEU) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached $189 million, up 92% year-over-year, with net income rising 141% to $30.6 million, driven by strong LEU deliveries and higher SWU sales volume and price.
Cash and cash equivalents stood at $227 million as of June 30, 2024, with working capital of $203 million and a strengthened balance sheet.
Pension obligations were reduced by 79–90% through annuitization, resulting in a $16.6 million remeasurement gain.
Continued production and deliveries of HALEU, positioning for long-term growth in domestic uranium enrichment.
Secured DOE waivers for Russian LEU imports for 2024–2025; future waivers for 2026–2027 remain uncertain.
Financial highlights
Q2 2024 revenue: $189 million (up from $98.4 million in Q2 2023); net income: $30.6 million (up from $12.7 million); EPS: $1.89 (diluted).
Gross profit for Q2 2024 was $36.5 million, up from $28 million in Q2 2023.
Operating income reached $21.1 million, compared to $14.4 million in Q2 2023.
Technical Solutions segment revenue rose to $19.4 million, with gross profit of $3.5 million.
Backlog totaled $2.7 billion, with $1.7 billion in LEU and $1.0 billion in Technical Solutions, extending to 2040.
Outlook and guidance
No formal guidance for 2024 due to market uncertainty from the war in Ukraine and regulatory changes.
Technical Solutions segment expected to be stronger in 2024 due to transition to a cost-plus incentive fee contract.
Company is pursuing DOE contracts and public/private funding to expand domestic enrichment capacity and HALEU production.
Margins expected to fluctuate due to timing of customer deliveries and contract mix.
No assurance of securing new contracts or additional waivers for Russian LEU imports beyond 2025.
Latest events from Centrus Energy
- Exclusive U.S. HALEU enricher, expanding to meet surging demand as Russian supply exits.LEU
Investor presentation11 Feb 2026 - Record revenue, $900M HALEU award, and $3.8B backlog drive growth and expansion plans.LEU
Q4 202511 Feb 2026 - Only U.S. HALEU producer, poised for growth as nuclear demand and policy support accelerate.LEU
JP Morgan Energy, Power and Renewables Conference3 Feb 2026 - Q3 revenue up 12% to $57.7M, net loss $5M, $3.8B backlog, major DOE awards, and regulatory risks.LEU
Q3 202418 Jan 2026 - Poised for growth as the top U.S. uranium enricher, backed by strong contracts and federal support.LEU
Investor Presentation30 Dec 2025 - Revenue up 38% to $442M, with $3.7B backlog and major DOE wins amid regulatory risks.LEU
Q4 202417 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditors, with strong governance focus.LEU
Proxy Filing1 Dec 2025 - Shareholders are being solicited to vote on annual meeting matters with no fee required.LEU
Proxy Filing1 Dec 2025 - Strong revenue growth, cash reserves, and strategic investments drive U.S. uranium leadership.LEU
Proxy Filing1 Dec 2025